Sime Darby Oils MD Mohd Haris Mohd Arshad said: "The importance of developing partnerships with institutions such as the UKM is that it allows for both the development and practical implementation of our findings."
KUALA LUMPUR: Sime Darby Oils (SDO) and Universiti Kebangsaan Malaysia (UKM) will carry out clinical trials to find out if the palm oil derived Tocotrienols can be used in treating non-alcoholic fatty liver disease (NAFLD).
In a joint statement issued on Tuesday, they said this is the world’s first comprehensive clinical trial whether Tocotrienols, an antioxidant in the vitamin E family, could be used in NAFLD treatment.
Already a subscriber? Log in.
Save 30% for ads-free and full access now!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
